Diclofenac Sodium Tablet, Film Coated, Extended Release
Product Images NDC 84386-103

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 84386-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (50 mg (60 Tablet Bottle))

Label for Diclofenac Sodium Extended-Release Tablets, USP, 100 mg, manufactured by Aurovitas Pharma Taizhou Co., Ltd. and distributed by Aurobindo Pharma USA, Inc. The label displays the product NDC 84386-103-01, an image of a yellow round tablet marked '100,' directions for storage, and a note to dispense the medication guide separately. The package contains 100 film-coated tablets for oral use.*

FDA Label Image

Chemical Structure (Diclofenac Str)

Chemical structure of diclofenac sodium showing two chlorine-substituted benzene rings linked by a nitrogen atom, with a carboxylate group (O-Na) attached to one ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.